CSPG4P13

Across TCGA pan-cancer cohorts, CSPG4P13 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of CSPG4P13’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CSPG4P13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CSPG4P13 is over-expressed in tumor, although a few such as KIRP and BLCA show the opposite, repressed pattern.

KIRC, HNSC, and KIRP are the cancer types where CSPG4P13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CSPG4P13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.709	<.001	12	view →
HNSC	Female	III,IV	+0.270	<.001	11	view →
KIRP	Female	All	−0.174	<.001	9	view →
BLCA	All	All	−0.167	.010	8	view →
LIHC	Female	All	+0.033	<.001	5	view →
BRCA	All	II,III,IV	−0.122	.002	4	view →
PAAD	Female	All	+0.290	.016	2	view →
UCEC	All	All	−0.179	.018	2	view →
CHOL	All	All	+0.109	.020	1	view →
LUAD	Female	All	−0.067	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

CSPG4P13–KIRC

Open the KIRC breakdown →